Six students at the School of Computer and Cyber Sciences will receive the prestigious Department of Defense Cybersecurity Scholarship, which guarantees them a job with a Department of Defense agency upon graduation.
There appears to be an unhealthy synergy between mental illness and prostate cancer, and researchers are working to dissect the relationship by first assembling the largest dataset ever of veterans with either condition or both.
Congratulations to five School of Computer and Cyber Sciences students who have been awarded the Department of Defense Cyber Scholarship (DoD CySP) for 2019.
MCG scientists hope non-invasive and better tests that measure a gene variant commonly found in bladder cancer could help improve patient outcomes.
Augusta University students awarded nine of 50 Department of Defense scholarships given nationwide.
Three Augusta University students received a prestigious scholarship from the Department of Defense.
In the 25 years since Desert Storm, the percentage of female veterans living with conditions linked to Gulf War Illness (GWI) may have surpassed that of their male counterparts, said Steven Coughlin, associate professor in the Augusta University...
Dr. Stuart A. Thompson, microbiologist and professor in the Division of Infectious Diseases at the Medical College of Georgia at Augusta University, was recently appointed to two review boards of the Congressionally Directed Medical Research...
Scientists have engineered a sort of biological barbell that can get inside cancer cells and do damage to two proteins that work independently and together to enable cancer’s survival and spread. Their therapeutic strategy includes a molecule on...
AUGUSTA, Ga. – Dr. Nita J. Maihle, a tumor virologist/biologist and educator, is leading the U.S. Department of Defense’s national initiative to enable early career ovarian cancer investigators to stay focused and successful in their fight against...
AUGUSTA, Ga. – Two existing chemotherapy drugs appear to be a powerful pair in targeting errant stem cells that are making breast cancer and enabling its spread and recurrence, scientists report. A combination of the drugs, 5-azacytidine and...